Health Care & Life Sciences » Biotechnology | Arena Pharmaceuticals Inc.

Arena Pharmaceuticals Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
19,435.00
60,508.00
107,979.00
22,136.00
90,082.00
29,399
Depreciation, Depletion & Amortization
8,202.00
9,161.00
10,042.00
4,994.00
4,278.00
3,759
Other Funds
-
-
-
320.00
-
13,880
Funds from Operations
12,174.00
91,501.00
82,805.00
14,992.00
74,839.00
122,093
Changes in Working Capital
84,974.00
9,897.00
15,308.00
77,131.00
8,197.00
10,119
Net Operating Cash Flow
72,800.00
101,398.00
98,113.00
62,139.00
66,642.00
132,212
Capital Expenditures
9,164.00
8,905.00
10,992.00
1,468.00
118.00
Sale of Fixed Assets & Businesses
60.00
47.00
2,232.00
954.00
789.00
Purchase/Sale of Investments
-
-
-
-
112,615.00
Net Investing Cash Flow
8,665.00
40,904.00
8,151.00
750.00
112,390.00
Issuance/Reduction of Debt, Net
1,664.00
2,057.00
2,492.00
2,979.00
3,518.00
Net Financing Cash Flow
1,651.00
3,168.00
101,136.00
2,289.00
245,287.00
Net Change in Cash
65,787.00
58,669.00
7,025.00
65,472.00
68,125.00
Free Cash Flow
63,636.00
110,303.00
109,105.00
62,953.00
66,755.00
Other Sources
439.00
49,762.00
609.00
-
-
Change in Capital Stock
3,315.00
5,225.00
103,628.00
370.00
248,805.00
Exchange Rate Effect
1.00
1,343.00
1,897.00
294.00
1,870.00
Other Uses
-
-
-
236.00
446.00

About Arena Pharmaceuticals

View Profile
Address
6154 Nancy Ridge Drive
San Diego California 92121
United States
Employees -
Website http://www.arenapharm.com
Updated 07/08/2019
Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.